Title : What we don’t know about hydrocephalus and It’s management
Abstract:
Symptomatic hydrocephalus has been treated primarily with cerebrospinal fluid (CSF) diversion since the 1950s. Ventriculoperitoneal and related shunting procedures have been highly effective at relieving acute, life-threatening elevations in intracranial pressure (ICP). However, despite decades of technical refinement, modern shunt systems remain fundamentally passive devices, offering limited ability to optimize ICP across the wide physiologic spectrum encountered from infancy through adulthood. As a result, many patients live with chronic under- or over-drainage, intermittent symptoms, and recurrent hospitalizations despite “functioning” shunt systems as evidenced on imaging.
Several foundational questions in hydrocephalus management remain unanswered. These include the definition of optimal ICP targets across developmental stages, the degree to which ICP should be allowed to fluctuate in response to posture, activity, and sleep, and how environmental factors such as barometric pressure and altitude may influence symptom burden. Current clinical decision-making relies heavily on indirect assessments—symptom reports, neuroimaging, and episodic invasive measurements—rather than continuous physiologic data. This gap is particularly consequential for pediatric patients, individuals with communication limitations, and those with complex or atypical symptom profiles.
This abstract will review the current state of hydrocephalus management, including contemporary valve technologies, programmable and gravitational shunt systems, and existing invasive ICP monitoring approaches. While these tools have improved safety and customization, they remain limited by their inability to provide real-time, longitudinal pressure data in the outpatient setting. As a result, clinicians are often forced to infer ICP dynamics indirectly, leading to delayed interventions and potentially avoidable morbidity.
We will also examine emerging concepts in neurobariatrics and pressure physiology, highlighting the dynamic and context-dependent nature of intracranial pressure regulation. Early evidence suggests that ICP is not a static variable but one influenced by development, behavior, and environment—factors that are not adequately captured by current treatment paradigms.
Finally, this discussion will identify critical technological, including the absence of ambulatory ICP monitoring, limited integration of physiologic data into clinical workflows, and the lack of evidence-based pressure targets tailored to individual patients. Addressing these gaps represents a necessary step toward shifting hydrocephalus care from crisis-driven management to proactive, data-informed treatment aimed at improving long-term daily neurologic health and quality of life.
